JP2002544172A5 - - Google Patents

Download PDF

Info

Publication number
JP2002544172A5
JP2002544172A5 JP2000616818A JP2000616818A JP2002544172A5 JP 2002544172 A5 JP2002544172 A5 JP 2002544172A5 JP 2000616818 A JP2000616818 A JP 2000616818A JP 2000616818 A JP2000616818 A JP 2000616818A JP 2002544172 A5 JP2002544172 A5 JP 2002544172A5
Authority
JP
Japan
Prior art keywords
composition
polypeptide
antibody
composition according
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000616818A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002544172A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/012163 external-priority patent/WO2000067793A1/en
Publication of JP2002544172A publication Critical patent/JP2002544172A/ja
Publication of JP2002544172A5 publication Critical patent/JP2002544172A5/ja
Pending legal-status Critical Current

Links

JP2000616818A 1999-05-06 2000-05-05 死ドメイン含有レセプター4 Pending JP2002544172A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13292299P 1999-05-06 1999-05-06
US60/132,922 1999-05-06
PCT/US2000/012163 WO2000067793A1 (en) 1999-05-06 2000-05-05 Death domain containing receptor 4

Publications (2)

Publication Number Publication Date
JP2002544172A JP2002544172A (ja) 2002-12-24
JP2002544172A5 true JP2002544172A5 (cg-RX-API-DMAC10.html) 2007-10-25

Family

ID=22456184

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000616818A Pending JP2002544172A (ja) 1999-05-06 2000-05-05 死ドメイン含有レセプター4

Country Status (5)

Country Link
EP (1) EP1178828A4 (cg-RX-API-DMAC10.html)
JP (1) JP2002544172A (cg-RX-API-DMAC10.html)
AU (1) AU4984300A (cg-RX-API-DMAC10.html)
CA (1) CA2373063A1 (cg-RX-API-DMAC10.html)
WO (1) WO2000067793A1 (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455040B1 (en) 1997-01-14 2002-09-24 Human Genome Sciences, Inc. Tumor necrosis factor receptor 5
ATE362982T1 (de) 1997-01-28 2007-06-15 Human Genome Sciences Inc ßDEATH-DOMAINß-ENTHALTENDER REZEPTOR 4 (DR4), EIN MITGLIED DER TNF-REZEPTOR SUPERFAMILIE, WELCHER AN TRAIL (APO-2L) BINDET
US8329179B2 (en) 1997-01-28 2012-12-11 Human Genome Sciences, Inc. Death domain containing receptor 4 antibodies and methods
US7279160B2 (en) 2000-05-02 2007-10-09 The Uab Research Foundation Combinations of DR5 antibodies and other therapeutic agents
TWI318983B (en) 2000-05-02 2010-01-01 Uab Research Foundation An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
US7476383B2 (en) 2000-05-02 2009-01-13 The Uab Research Foundation Antibody selective for DR4 and uses thereof
KR100932577B1 (ko) * 2001-05-18 2009-12-17 기린 홀딩스 가부시키가이샤 항 trail-r 항체
MXPA03010747A (es) 2001-05-25 2004-03-02 Human Genome Sciences Inc Anticuerpos que se unen inmunoespecificamente a receptores de ligando inductor de apoptosis relacionado con factor de necrosis tumoral.
WO2003013584A1 (en) * 2001-08-09 2003-02-20 Genset S.A. Xafinix agonists and antagonists for use in the treatment of metabolic disorders
ES2357225T3 (es) * 2001-11-01 2011-04-20 Uab Research Foundation Combinaciones de anticuerpos anti-dr5 y anticuerpos anti-dr4 y otros agentes terapéuticos.
AU2005318086B2 (en) * 2004-12-23 2011-07-07 Merck Serono Sa BCMA polypeptides and uses thereof
BRPI0606791A2 (pt) 2005-02-02 2010-02-09 The Uab Research Foundation métodos de reverter ou prevenir a resistência de uma célula a um agonista do receptor da morte, de triar uma célula quanto a um biomarcador da resistência a um agonista do receptor da morte, de monitorar a resistência a um agonista do receptor da morte em um indivìduo, de induzir seletivamente a apoptose em uma célula alvo expressando um receptor da morte, de tratar de um indivìduo com cáncer, de tratar de um indivìduo com uma doença inflamatória ou autoimune, de bloquear a ligação da proteìna contendo card a um receptor da morte em uma célula, de bloquear a associação de um iap com o receptor da morte e de triar um modulador de uma proteìna contendo card, composição, ácido nucleico isolado, vetor, célula, e, polipeptìdeo isolado
ES2812208T3 (es) 2013-03-14 2021-03-16 Bristol Myers Squibb Co Combinación de un agonista de DR5 y un antagonista de anti-PD-1 y métodos de uso

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
ATE362982T1 (de) * 1997-01-28 2007-06-15 Human Genome Sciences Inc ßDEATH-DOMAINß-ENTHALTENDER REZEPTOR 4 (DR4), EIN MITGLIED DER TNF-REZEPTOR SUPERFAMILIE, WELCHER AN TRAIL (APO-2L) BINDET
AU8400398A (en) * 1997-07-11 1999-02-08 Trustees Of The University Of Pennsylvania, The Nucleic acid encoding a novel chemotherapy-induced protein, and methods of use
PT1053256E (pt) * 1998-01-26 2011-09-28 Genentech Inc Anticorpos para o receptor de morte 4 (dr4) e utilizações destes

Similar Documents

Publication Publication Date Title
JP2002543151A5 (cg-RX-API-DMAC10.html)
JP4764627B2 (ja) 新生物疾患又は免疫不全を処置するためのヒト化免疫調節性モノクローナル抗体
ES2305110T3 (es) Anticuerpos contra la il-1 beta humana.
JP4716350B2 (ja) 潜伏期膜タンパク質に対する抗体およびそれらの使用
EP0633931B1 (en) Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
US7767405B2 (en) Immunocytokine sequences and uses thereof
JP3360108B2 (ja) 二つのエフェクター機能を有する二元特異性異種抗体
JP2006505244A5 (cg-RX-API-DMAC10.html)
WO2011137687A1 (zh) 一种抗癌胚抗原抗体及其应用
EP1159003B1 (en) Anti-tnf alpha antibodies in therapy of steroid resistant asthma
EP1706423A2 (en) Therapeutic and diagnostic anti-hsp 70 antibodies
JP2012522531A (ja) Il−17brに対する抗体
EP0881910A1 (en) Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
US20070202102A1 (en) High-Yield Method For The Production Of Human Antibodies Blocking The Biological Activity Of A Human Cytokine
Nishimoto et al. 2-3). Anticytokine therapy in autoimmune diseases
US9605075B2 (en) Hybridoma cell line G250 and its use for producing monoclonal antibodies
CN114409766B (zh) 一种eb病毒的中和性抗体及其应用
US12583935B2 (en) Anti-human CD47 antibody and antigen-binding fragment thereof, and preparation method therefor and use thereof
Xiang et al. Targeting gamma interferon to tumor cells by a genetically engineered fusion protein secreted from myeloma cells
CN116063512B (zh) 多功能重组抗体及其制备方法和应用
JP2026501279A (ja) 抗インターロイキン-6抗体の投与による心筋炎の処置
FI102115B (fi) Diagnostiikassa käytettävä monoklonaalinen vasta-ainekoostumus ja sitä sisältävä testipakkaus
TW202222836A (zh) 特異性結合糖基化ceacam5的抗體
EP1733736A2 (en) Method of producing recombinant antibodies against tumours